Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $290 Million
  • Q2 2024

Johnson & Johnson has filed its 13F form on August 09, 2024 for Q2 2024 where it was disclosed a total value porftolio of $290 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $84.9M, Cv Rx, Inc. with a value of $49.2M, Legend Biotech Corp with a value of $36.1M, Nanobiotix S.A. with a value of $28.1M, and Meira G Tx Holdings PLC with a value of $28M.

Examining the 13F form we can see an decrease of $185M in the current position value, from $475M to 290M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $290 Million
Healthcare: $290 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.31B
$84.9 Million 29.31% of portfolio
2,449,183
Q3 2021 New
$162M
$49.2 Million 16.99% of portfolio
4,103,430
Q1 2024 Added 17.39%
$8.42B
$36.1 Million 12.46% of portfolio
814,586
Q2 2023 Reduced 50.0%
$173M
$28.1 Million 9.71% of portfolio
5,623,816
Q1 2024 Added 486.04%
$191M
$28 Million 9.66% of portfolio
6,641,064
Q4 2022 Added 129.12%
$3.62B
$21.9 Million 7.55% of portfolio
357,939
Q4 2022 Reduced 58.57%
$1.28B
$14.2 Million 4.89% of portfolio
748,062
Q4 2021 New
$390M
$11.1 Million 3.83% of portfolio
3,379,064
Q3 2021 New
$2.27B
$6.44 Million 2.22% of portfolio
247,598
Q3 2022 Reduced 80.36%
$36.3M
$4.87 Million 1.68% of portfolio
3,636,363
Q2 2024 New
$330M
$1.17 Million 0.4% of portfolio
158,852
Q1 2024 Reduced 50.0%
$40M
$1.07 Million 0.37% of portfolio
1,074,658
Q3 2021 New
$352M
$991,000 0.34% of portfolio
299,669
Q1 2024 Reduced 24.1%
$29.7M
$653,000 0.23% of portfolio
1,923,201
Q1 2024 Reduced 9.85%
$162M
$552,000 0.19% of portfolio
311,967
Q1 2024 New
$59.6M
$441,000 0.15% of portfolio
364,472
Q1 2024 Reduced 50.0%
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 102.76%
Rapport Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Contineum Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $290 Million
  • Prior Value $475 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 09, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 3 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email